Dyspepsia, peptic ulcer disease, and esophageal reflux disease.
作者信息
Schwartz Mark D
机构信息
Division of Primary Care, Department of Medicine, New York University School of Medicine and Veterans Affairs, New York Harbor Healthcare System Medical Service (111), 423 E 23rd St, New York, NY 10010, USA.
出版信息
West J Med. 2002 Mar;176(2):98-103.
Abstract
摘要
相似文献
1
Dyspepsia, peptic ulcer disease, and esophageal reflux disease.
West J Med. 2002 Mar;176(2):98-103.
2
Whom should we "test and treat" for Helicobacter pylori?
BMJ. 2014 May 20;348:g3320. doi: 10.1136/bmj.g3320.
3
Helicobacter pylori and non-malignant upper gastrointestinal diseases.
Helicobacter. 2016 Sep;21 Suppl 1:30-3. doi: 10.1111/hel.12337.
4
Management issues in dyspepsia: current consensus and controversies.
Scand J Gastroenterol. 2004 Oct;39(10):913-8. doi: 10.1080/00365520410003452.
5
Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study.
Am J Gastroenterol. 2008 May;103(5):1106-13. doi: 10.1111/j.1572-0241.2007.01770.x. Epub 2008 Apr 28.
6
[Dyspepsia and reflux. Systematic literature review from SBU].
Lakartidningen. 2007;104(18):1414-7.
7
Dyspepsia, peptic ulcer, and H. pylori: a remembrance of things past.
Am J Gastroenterol. 2010 Mar;105(3):572-4. doi: 10.1038/ajg.2009.709.
8
[Dyspepsia, Ulcer Disease – Helicobacter pylori, Gastroesophageal Reflux Disease].
Praxis (Bern 1994). 2016 Jun 8;105(12):693-7. doi: 10.1024/1661-8157/a002367.
9
Changing prevalence of some selected gastrointestinal diseases vis-à-vis H. pylori infection.
Hepatogastroenterology. 2011 May-Jun;58(107-108):1062-6.
10
Comparison table: Drugs for GERD and peptic ulcer disease.
Med Lett Drugs Ther. 2018 Jan 15;60(1538):e16-e18.
引用本文的文献
1
Diagnostic utility of alarm features in predicting malignancy in patients with dyspeptic symptoms.
Indian J Gastroenterol. 2021 Apr;40(2):183-188. doi: 10.1007/s12664-021-01155-x. Epub 2021 Apr 8.
2
Anti-, Anti-Inflammatory, Cytotoxic, and Antioxidant Activities of Mace Extracts from .
Evid Based Complement Alternat Med. 2020 Mar 29;2020:7576818. doi: 10.1155/2020/7576818. eCollection 2020.
3
Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy.
Metabolites. 2017 Dec 23;8(1):2. doi: 10.3390/metabo8010002.
4
Do Statins Increase the Risk of Esophageal Conditions? Findings from Four Propensity Score-Matched Analyses.
Clin Drug Investig. 2018 Feb;38(2):135-146. doi: 10.1007/s40261-017-0589-x.
5
Insights into gastric neuroendocrine tumors burden.
Chin J Cancer Res. 2017 Apr;29(2):137-143. doi: 10.21147/j.issn.1000-9604.2017.02.06.
6
Sensitivity of ultrasonography for gastric cancer diagnosis in symptomatic patients.
Dig Dis Sci. 2009 Jun;54(6):1257-64. doi: 10.1007/s10620-008-0474-9. Epub 2008 Aug 29.
7
Helicobacter pylori induces apoptosis in Barrett's-derived esophageal adenocarcinoma cells.
J Gastrointest Surg. 2003 Jan;7(1):68-76. doi: 10.1016/S1091-255X(02)00129-4.
本文引用的文献
1
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.
CMAJ. 2000 Jun 13;162(12 Suppl):S3-23.
2
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Cochrane Database Syst Rev. 2000(2):CD002095. doi: 10.1002/14651858.CD002095.
3
Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997.
Vital Health Stat 13. 1999 Nov(143):i-iv, 1-39.
4
Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.
BMJ. 1999 Feb 20;318(7182):502-7. doi: 10.1136/bmj.318.7182.502.
5
Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology.
Am J Gastroenterol. 1998 Dec;93(12):2330-8. doi: 10.1111/j.1572-0241.1998.00684.x.
6
Nonulcer dyspepsia: a look into the future.
Mayo Clin Proc. 1996 Jun;71(6):614-22. doi: 10.4065/71.6.614.
7
Management of Helicobacter pylori infection in ulcer disease.
Hosp Pract (1995). 1996 Jan 15;31(1):63-4, 67-9, 73-5.
8
Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.
JAMA. 1996 Feb 28;275(8):622-9. doi: 10.1001/jama.275.8.622.
9
Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.
N Engl J Med. 1993 Feb 4;328(5):308-12. doi: 10.1056/NEJM199302043280503.
10
Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia.
Lancet. 1994 Apr 2;343(8901):811-6. doi: 10.1016/s0140-6736(94)92023-0.
Zotero 插件